Category

Press Release
Epic’s Comprehensive Cancer Profiling™ now includes the broadest ctDNA assay PredicineATLAS™   Predicine, a molecular insights company headquartered in Hayward, California and Epic Sciences, Inc. today announced they have entered into a global strategic partnership to offer biopharmaceutical companies access to both Predicine’s ctDNA-based testing and Epic’s CTC-based testing. Predicine’s lead offering is PredicineATLAS™, the...
This unprecedented time is especially troubling for people fighting with cancer. At Predicine, our primary focus remains our commitment to deliver genomic testing to physicians and cancer patients in need. Our global labs in San Francisco and Shanghai remain open and operational with precautionary measures put in place to ensure we are keeping our employees safe as...
Predicine and Merck KGaA, Darmstadt, Germany collaboratively highlight the importance of multi-parametric profiling of ctDNA and cfRNA for holistic molecular insight for detecting driver mutation, monitoring disease burden and drug resistance in advanced stage colorectal cancer. Predicine, a molecular insights company headquartered in Hayward, California, with global footprints in China, today announced results from a...
Predicine today announced a strategic partnership with FMD to help biopharma companies accelerate biomarker-driven clinical trials and concurrent New Drug Application (NDA) submissions in the U.S. and China. The collaboration structure allows for global development of novel oncology therapies for biopharmaceutical companies, including global clinical trial support, regulatory support, and biomarker-driven drug development, and CDx...
Liquid biopsies are being widely studied as a minimally-invasive means for early detection of cancer, monitoring of disease progression, and guiding treatment decisions. However, recent studies in JAMA Oncology reported the discordance between circulating tumor DNA (ctDNA) assay results from commercial platforms such as Guardant Health and PGD, raising questions and concerns regarding the performance...
Predicine, a molecular insights company, announced today that its CLIA-certified genomic sequencing laboratory in the San Francisco Bay Area has received accreditation from the College of American Pathologists (CAP) for meeting the highest standards in quality, operations, and patient safety. Predicine received CAP accreditation for its Shanghai facility last month. The current dual CAP accreditation...
Predicine, a molecular insights company with business operations in U.S. and China, announced today that the company has received accreditation from the College of American Pathologists (CAP) for its genomic sequencing laboratory in Shanghai, China. This CAP accreditation is based on the satisfactory results of a recent on-site inspection as part of the CAP’s Accreditation...
Predicine and Flagship Biosciences are excited to announce a strategic venture. The synergistic combination of Predicine’s GeneRADAR molecular insights platform with Flagship’s artificial intelligence-enabled cTA® digital pathology platform provides complimentary and comprehensive biomarker profiling to empower clinical trials in the immuno-oncology (IO) space. IO therapies have changed the way we think about patient selection for...
Predicine and Kintor Pharma today announced that new data on Proxalutamide (GT0918) in a Phase I/II clinical trial (NCT02826772) will be presented at the European Society for Medical Oncology (ESMO) 2018 Congress in Munich, Germany. Metastatic castration resistant prostate cancer (mCRPC) is a complex disease with distinct molecular features in relation to genomic instability and...
Predicine, a precision medicine company based in Silicon Valley, announced today that the company has entered into a global strategic partnership with Suzhou Kintor Pharmaceuticals to increase the speed and efficiency of biomarker-driven global clinical trials for Kintor’s novel oncology drugs and the development of companion diagnostics for FDA and CFDA approvals. Kintor will leverage...
1 2